abstract |
The present invention encompasses compounds of formula (I) wherein the groups R 2 to R 5 , A, X and q have the meanings given in the claims and specification, their use as inhibitors of CDK8/19, pharmaceutical compositions which contain compounds of this kind and their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases. |